Afterwork Event: Carve‑Outs in Pharma and Beyond 📍 Campus Biotech, Geneva 📅 Thursday, October 1, 2026
Join us for an exclusive evening co‑hosted by Swiss Healthcare Licensing Group (Swiss HLG) and Gyrus Capital, dedicated to one of the most effective value‑creation strategies in healthcare M&A: carve‑outs.
Carve‑outs empower companies and investors to unlock value, sharpen focus, and build independent businesses positioned for long‑term growth.
🎤 Keynote Speaker: Etienne Jornod, Chairman of OM Pharma, will share insights from the successful spin‑out of OM Pharma from Vifor — and the lessons learned from this transformative transaction.
💡 Additional Perspectives: Experts from Deloitte and Gyrus Capital will provide strategic, financial, and operational views on carve‑out transactions.
Networking Apéro: After the presentations, enjoy an apéro — the perfect chance to exchange ideas, share experiences, and connect with peers from the Swiss healthcare and life sciences community.
🕔 Schedule
We look forward to welcoming you in Geneva.
